All Eyes On Beijing As Critical Disease Coverage Details Emerge
This article was originally published in PharmAsia News
Executive Summary
China’s second largest pharmaceutical market could be the first directly administrated city in China to issue a major disease coverage plan. The move is expected to benefit manufacturers of oncology drugs the most.